Thermo Fisher Scientific Announces Collaboration to Advance Noninvasive Risk Assessments of Pregnancy Outcomes
San Jose, Calif. – (April 16, 2019) – Thermo Fisher Scientific, the world leader in serving science, and NX Prenatal Inc., a recognized leader in the detection, monitoring and management of pregnancy-related complications using novel exosome-based methods, have entered into a collaboration to develop clinical mass spectrometry-based proteomics assays to monitor fetal health in utero and assess the risk... Read more